The safe administration of anti-CD19 CAR T cells in two women with concomitant myasthenia gravis and Lambert-Eaton myasthenic syndrome resulted in profound B cell depletion and normalization of acetylcholine receptor and voltage-gated calcium channel N-type autoantibody levels, which paralleled significant neurological responses (137). The gene discussed is CD19; the disease is myasthenia gravis.